Introduction
The pancreatic acinar cell is highly specialized for synthesis and storage of digestive enzymes. These enzymes are stored in zymogen granules and secreted when the pancreas is stimulated. We are examining how zymogen granules are organized, focusing on sulfated granule components. We recently described the initial characterization of the major sulfated glycoprotein in the mouse pancreas, gp300 (8) . gp300 is a peripheral membrane protein localized to the luminal face of the granule membrane. Because gp300 was not found to be secreted, we proposed that gp300 was a structural component of the granule and that it might be involved in granule biogenesis. Others have proposed that sulfated macromolecules could be involved in the protein condensation process that occurs during the conversion of condensing vacuoles to mature zymogen granules (1,22-24). The idea is that negatively charged sulfates could bind by electrostatic interactions to positive charges on the digestive enzymes, thereby causing protein aggregation. Since gp300 is membrane-associated, it could function to bind such aggregating protein to the nascent granule membrane via electrostatic interactions of its sulfate moieties.
We have also recently found that gp300 has increased biosyn-( -I -) mouse, we discovered that the pancreatic acinar tissue displays a dramatic pathology (7). The acinar lumina are greatly distended and the lumens are filled with protein aggregates. In addition, gp300 was found to line the distended luminal membrane, suggesting a relationship between the pathology and increased expression of gp300. Therefore, we are exploring whether gp3OO plays an important role in granule formation and function. If gp300 has an essential role in granule formation and function, it should be required for granule formation. An easily testable prediction of this hypothesis is that gp300 should be expressed as zymogen granules form during fetal development. We found that gp300 expression occurred at the same time that acinar cells differentiated and statted to accumulate zymogen granules. In these studies, we also observed that complex changes in the carbohydrate composition of gp300 occur during development. This information may provide insights into the function of gp300 as a major granule membrane component.
Materials and Methods
Animals. Swiss Webster mice 6-12 weeks of age were bred and the morning Of appearance ofa vagmal plug was considered embryonic D a y 0.5 (E0.5). Fetal pancreatic tissue was obtained under a dissecting microscope and was used for biochemical and morphological analyses. Fetuses from the same 57 developmental age were pooled as necessary to provide adequate amounts of tissue for biochemical analyses.
Cytochemical and Morphological Procedures. Pancreas was fixed in 4% paraformaldehyde and cryoprotected in 2.3 M sucrose in PBS. Semi-thin (2.5-pm) cryosections were prepared as previously described (8) for immunolocalization and lectin labeling. The lectins used and the secondary reagents for their detection are as follows. Datura rtrumonium agglutinin (DSA), peanut agglutinin (PNA), and Mauckiaamrresi'agglutinin (MAA) were all obtained as digoxigenin conjugates from Boehringer Mannheim Biochemicals (Indianapolis, IN). Ufex europueus I (UEA-I) was obtained as a biotin conjugate from EY Laboratories (San Mateo, CA). DSA, UEA-I, a i d PNA were used at 20 pg/ml and MAA was used at 50 pg/ml. All lectins were diluted in the blocking reagent supplied with the Boehringer Mannheim lectin differentiation kit. Binding of the digoxigenin-conjugated lectins was detected with a sheep anti-digoxigenin-fluorescein isothiocyanate (FITC) conjugate (Boehringer Mannheim), and the biotin conjugated lectin was detected with a streptavidin-FITC conjugate (Zymed; S. San Francisco, CA).
Tissue sections were also immunolabeled with polyclonal antisera to amylase and gp300 (7). In addition, small pieces ("l-mm cubes) of tissue were fixed in 2% paraformaldehyde, 0.1% saponin in PBS for confocal microscopy. The fixed tissue pieces were washed in PBS for 1 hr, followed by overnight incubation at 4'C on a rotator with anti-gp300 antiserum (1:500 dilution in 2% normal donkey serum). The secondary antibody was donkey anti-rabbit-FIX (Jackson ImmunoResearch; West Grove, PA) diluted 1:lOO in 2% normal donkey serum. Before observation, sections and pieces of tissue were mounted on glass slides and coverslipped with Slow-Fade (Molecular Probes; Eugene, OR). For conventional indirect fluorescence, sections were observed on a Nikon Diaphot (Nikon; Garden City, NY) equipped with fluorescence attachments. For confocal microscopy, a Meridian (Okemos, MI) confocal microscope was used. For electron microscopy, tissue was fixed with 1.6% glutaraldehyde, 4% paraformaldehyde in PBS. The tissue was processed and embedded in Polybed 812 (Polysciences; Warrington, PA) as described (8) .
Western Blot Analyses of Amylase and gp300. Pancreatic samples were homogenized on ice in 10 mM Tris, pH 7.4, with phenylmethylsulfonyl fluoride, leupeptin, pepstatin A, and benzamidine, with a probe-tip sonicator. Protein concentrations were determined by the method of Bradford (3) using reagents from Bio-Rad (Richmond, CA). Protein samples were separated by SDS-PAGE and transferred to nitrocellulose using Tridglycine without methanol as the transfer buffer. Pre-stained molecular weight standards were used (Rainbow Markers; Amersham, Arlington Heights. IL). For probing with anti-gp300 antiserum or anti-amylase, the blots were blocked with 5% dry milk, 0.05% Tween-20 in PBS. The blots were then probed with anti-gp300 diluted 1:5000 or anti-amylase (Sigma; St Louis, MO) diluted 1:5000, in dry milk block solution. This was followed by washing and incubation with donkey anti-rabbit Ig-alkaline phosphatase (Jackson ImmunoResearch) diluted 1:1000 in block solution, and the signal was developed with nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP). Amylase activity was assayed by the method of Jung (15) , and the reagent was calibrated using purified amylase (Worthington; Freehold, NJ).
Blots for DSA, UEA-I, and MAA were blocked with the reagent supplied by Boehringer Mannheim in their lectin differentiation kit. PNA blots were blocked with 1% bovine serum albumin, 0.01% Triton X-100 in Trisbuffered saline (TBS). DSA, UEA-I, and PNA were used at 2 pg/ml and MAA was used at 5 pg/ml diluted in 1% bovine serum albumin, 0.01% Triton X-100 in TBS. Binding of the digoxigenin-conjugated lectins was detected with a sheep anti-digoxigenin-alkaline phosphatase conjugate (Boehringer Mannheim), and the biotin-conjugated lectin was detected with avidin-alkaline phosphatase (Zymed), all diluted in 1% bovine serum albumin, 0.01% Triton X-100 in TBS. The blots were developed with NBTIBCII?
Lectin specificity controls included glycosidase digestions and use of competing sugars. DSA reactivity was removed from blots by PNGase F digestion (8); UEA-I reactivity was blocked by 0.5 M fucose (not shown); PNA reactivity was blocked by 0.1 M lactose (not shown); and MAA reactivity was abolished by sialidase digestion (8). The major band in all lectin blots was gp300. This was confirmed by separating gp300 immunoprecipitated from adult pancreas (8) by SDS-PAGE, followed by transfer and lectin blot analyses (not shown).
Biosynthetic Radiolabeling of Sulfated Pancreatic Proteins. Pancreatic tissue from fetal animals (E15.5-E17.5), or isolated pancreatic acini [E18.>-adult; prepared as previously described (S)], were incubated overnight in nominally sulfate-free medium supplemented with 200 pCi/ml (3'S]-sulfate. Labeled samples were separated on 7.5% SDS-PAGE, followed by autoradiography.
Results
We have postulated that gp300 is an essential component of the pancreatic zymogen granule. Therefore, gp300 expression should be coordinated with the appearance of zymogen granules during fetal development of the pancreas. We used amylase activity and immunoreactivity as a measure of acinar cell differentiation and zymogen granule accumulation. Amylase is one of the major exocrine secretory proteins of the acinar cell and is packaged with the other digestive enzymes in the zymogen granule. Zymogen granules appear in the mouse pancreas on about E15.5 ( Figure 1A ). By E18.5, the entire acinar cell cytoplasm is filled with granules (Figure 1B) . Amylase enzymatic activity and immunoreactivity in fetal development of the mouse pancreas were assessed over the period of El3.5 through neonate. As described by others (21), amylase levels in the developing pancreas increase from a protodifferentiated level at E14.5 of mouse development and reach a maximal specific activity at E18.5, with a more than 1000-fold increase in activity during this period (Figure 2 ). The increase in digestive enzyme accumulation is due to differentiation of the acinar tissue, as shown in Figure 1 .
During the same developmental period, expression of gp300 increased in parallel with amylase expression and accumulation of zymogen granules, as shown by Western blotting. gp300 levels are first detectable at E15.5 and increase to a maximum between E18.5 and birth ( Figure 3A) . By confocal microscope immunolocalization, gp300 can be localized as early as E16.5 to small-diameter zymogen granules ( Figure 4C ) typical of this early developmental stage (10) . By E18.5, zymogen granules are larger in diameter and the membrane localization becomes obvious ( Figure 4D ), as it also is in adult acinar cells ( Figures 4A and 4B ).
The migration of gp300 from fetal and neonatal pancreas on SDS-PAGE was slightly more rapid than in adult samples ( Figure  3 ), suggesting that post-translational processing of this sulfated glycoprotein is different during development than in adult tissue. To determine when the change occurred, we examined gp300 in postnatal tissue. The adult SDS-PAGE migration pattern of gp300 was gradually obtained, occurring from postnatal Days 3 (P3) through Pl6 ( Figure 3B ). The minor immunoreactive bands in some lanes are likely to be biosynthetic intermediates and degradation products of mature gp300. Affinity-purified anti-gp300 antiserum against the major immunoreactive band labeled these bands demonstrating their immunological relatedness to mature gp300 (data not shown). Development of the pancreas continues postnatally, and dietary adaptations also occur as the pups are weaned from mother's milk to solid rodent chow (27) . Attainment of the adult Mr for gp300 occurred at about the time of weaning, suggesting a dietary influence on post-translational processing of this glycoprotein. During the postnatal period, the relative amount of gp300 decreased from the high neonatal level to that of the adult. The change was gradual, with the greatest changes observed between neonate and P1 and between P9 and PI6 ( Figure 3B ).
During the postnatal period, acinar cells continue to differentiate, and cytological changes also occur as the tissue starts to actively secrete its stored enzymes. The number of granules decreases and the zymogen granule size decreases also ( Figures IC and ID) relative to the large granules present at E18.5 ( Figure 1B ). More dramatic during the postnatal period is a decrease in amylase content of the tissue. The drop in amylase content is most apparent at P3 (Figure 2) , which corresponds to the time when the developing pancreas becomes responsive to secretagogues (28) . At P9 amylase content increases, and the tissue has more granules that are larger in size than at P3 ( Figure ID To investigate what changes in post-translational processing of gp300 occur during fetal and postnatal development, we explored the glycosylation of gp300 at different times using lectin blot analyses. As previously described. gp300 from adult tissue contains both N-and 0-linked oligosaccharides, with sulfate on the 0-linked carbohydrate (8). gp300 binds a number of lectins, including DSA, UEA-I, PNA, and MAA, indicating the presence of specific carbohydrate moieties (13) .
Changes in the intensity of DSA binding [GalP( 1-4)GlcNAc] to gp300 during development were similar to that of total gp300 immunoreactivity during fetal and postnatal (Figure 5 ) development. DSA binding was apparent but weak at E16.5 and increased to its strongest at E18.5. Again, the apparent Mr of the reactive band was slightly less in the neonate compared to the adult tissue. There were small changes in intensity of DSA binding postnatally, with a decrease after birth (Pl-P3) and an increase to the adult intensity about the time of weaning (P21). for extended times (not shown). During postnatal development UEA-I binding was barely detectable at P1 and remained very wcak through P9. UEA-I binding began to increase at Pl6 and rose to adult levels over the next 2 weeks of postnatal development. UEA-I binding to the other bands that appear on these blots could not be competed off with 50 mM fucose, and therefore they are nonspecific.
During fetal development, PNA binding [GalD( 1-3)GalNAcI to gp300 on Western blots of fetal tissue became apparent at E17 and was generally weaker than gp300 immunoreactivity ( Figure 5 ). Postnatal changes in PNA binding levels to gp3OO were different from the gp300 immunoreactivity. The PNA signal became progressively wcaker from P1 through P3 and virtually disappeared at P9 (Figure 5) . At P16 the PNA binding reappeared, and the signal increased and achieved the adult intensity over the next weeks.
During fetal development, MAA binding [sialic acida (2-3)GaIl to gp300 paralleled that of immunoreactive gp300. The maximal signal was between E18.5 and neonate and the band was faster migrating through the neonatal time ( Figure 5 ). After birth. MAA binding was different from total gp300 immunoreactivity. MAA binding increased between P3 and P9, and thereafter decreased to adult levels ( Figure 5 ). The panem of MAA binding during postnatal development appears to be reciprocal to that of PNA binding ( Figure 5 ).
For PNA and MAA. gp300 is virtually the sole glycoprotein obscrvcd on Western blots of pancreatic tissue. These observations suggest that PNA and MAA. which bind primarily to gp300, could be used to localize gp300 in sections of pancreatic tissue. Such localization could reveal the changes in glycosylation of gp300 during development and the possible subcellular distribution of differentially glyrosylated forms of gp300. In E16.5 fetal tissue. PNA binding was luminal in developing acini ( Figure 6A ). Label was also wcakly observed in zymogen granules, but the intensity of labcling was too weak to document compared to the luminal signal. In adult tissue, PNA was also largely on the luminal membrane (Figure bB) , and granules were labeled too weakly to document. By contrast, MAA labeling of Ei6.5 tissue was largely on zymogen granules ( Figure 6C ). MAA labeling in adult tissue was weaker than in the fetal tissue, but its localization was similar: most labcling was on granules, with some luminal membrane labcling ( Figure 6D ).
For comparison, we also performed cytochemistry with DSA and UEA-I. DSA labeled developing acinar cells at E16.5, with labeling on all surfaces of the plasma membranes as well as on zymogen granules ( Figure 7A ). In adult tissue. DSA labeling was similar to that in the fetal tissue ( Figure 7B ). No specific UEA-I labcling was observed at E16.5 (not shown). In adult tissue, UEA-I labeling was predominantly on the apical plasma membrane ( Figure 7C ).
Because gp300 is the major sulfated glycoprotein of the acinar cell. we also examined sulfation during pancreatic development. Because sulfation was studied by metabolic incorporation of [ 35S]-sulfate, it was not possible to make relative quantitative comparisons as was done for the lectin blots that detected total levels of the glycoconjugates present. Labeling of gp300 with [ 3'S]-sulfatc was not observed at E15.5 (Figure 8) . wen though gp300 is cxprcssed at this time. This may be due to the very small amount of fetal tissue available, compounded by the relatively low lwcls of gp300 expressed at this time. Sulfate incorporation into gp300 was first detected at E16.5. After this time, gp300 was observed to be sul- Understanding the .,rmation and function of regL.,ted secretory granules requires detailed information not only about the contents of such granules but also about their membrane composition. We have recently characterized the major sulfated glycoprotein of the mouse acinar cell, gp300, which is a granule membrane component. We proposed that gp300 is necessary for granule formation and function (8) . and therefore gp300 expression should be coordinated with the appearance of granules during fetal development.
Another zymogen granule membrane component, GP-2, which is a glycosylphosphatidyl inositol-linked glycoprotein attached to the inner face of the granule membrane (19) . was suggested to have an essential function in granule formation (12) . As a critical test of the proposed role of GP-2. DittiE and Kern (9) examined expression of GP-2 during development and under conditions in which expression of digestive enzyme genes was modulated by hormonal stimulation. They demonstrated that GP-2 is not expressed during fetal development and that its expression is significant only at the
-

viously used PNA to investigate glycoconjugates in mouse pancreas. They demonstrated in the adult mouse pancreas that the apical plasma membrane was strongly labeled, whereas the granules were more weakly labeled by this lectin. We confirmed this in the present study and identified the PNA binding site as gp300.
Various other studies of glycoconjugates in acinar cells have been reported. One study in rats followed the developmental expression of galactosyltransferase. Expression of this enzyme activity occurred during differentiation of the acinar cells, although the authors of that study did not make the connection between zymogen granule accumulation and activity of this enzyme (6). Developmental expression of galactosyltransferase is to be expected when gp300 expression is turned on, since gp300 is a major galactose-containing glycoconjugate of the differentiating acinar cell. Another study in rat used the lectin Hefixpomutia (HPA), which recognizes unsubstituted GalNAc. It was observed that HPA labeling was stronger on condensing vacuoles than on mature granules and that the HPA label was strong on the luminal plasma membrane (16) . This is time of weaning. Granules form without measurable GP-2 and therefore GP-2 cannot be essential for granule formation. In support of the proposed importance of gp300, we have now demonstrated that gp300 protein expression parallels the expression of amylase and the accumulation of zymogen granules in fetal pancreatic development. The onset of the increase in gp300 and amylase expression was coincident, and relative changes in gp300 and amylase occurred in parallel during fetal development. gp300 is a glycoprotein, and we observed that fetal gp300 had a smaller apparent molecular weight on SDS-PAGE compared with adult gp300. The nature of this difference was due to changes in post-translational processing of gp300 during development. The most dramatic change was that gp300 contained no detectable fucose until about the time of weaning. Similar changes in UEA-I binding to Paneth cells have been reported during mouse intestinal development (4). Because the Paneth cell also expresses gp300 ( 8 ) , the postnatal acquisition of UEA-I binding to Paneth cells (11) may be on gp300 in Paneth cell granules. The change in gp300 fucosylation is likely to be caused by developmental expression of a fucosyltransferase at the time of weaning. An alternative possibility is that terminal glycosylation of oligosaccharides on gp300 may be different fetally and postnatally. It has been shown for intestinal lactase that the fetal protein is highly sialylated, whereas the adult enzyme is fucosylated (5). The authors of the study suggested that the same terminal site was differentially modified during development. However, the changes we observed on gp300 for sialic acid (MAA binding) were not sufficient to explain the dramatic increase in fucosylation (UEA-I binding).
We have shown that gp300 is the primary PNA binding glycoprotein in the mouse acinar cell. Schulte and Spicer (25) have presimilar to our observation that PNA binding is stronger on the apical plasma membrane than on granules. These data suggest that carbohydrate modification occurs during granule maturation and after delivery of granule components to the plasma membrane by exocytosis.
An interesting observation along these lines is that gp300 appears to have reciprocal levels of PNA and MAA binding, and changes occur during postnatal development. This suggests that terminal sialylation of galactose residues is variable, which will have the effect of reciprocally altering MAA and PNA binding. We also observed that MAA binding was relatively stronger in zymogen granules, whereas PNA binding was stronger on the apical plasma membrane. In several studies it has been demonstrated that glycoproteins can have their carbohydrates modified during recycling of the protein from the plasma membrane back to the Golgi apparatus. The hepatocyte bile canalicular membrane protein dipeptidyl peptidase IV (DPP IV) was shown to undergo deglycosylation at the plasma membrane, losing fucose (18) . On internalization, DPP IV was found to acquire new fucose and sialic acid, demonstrating that these terminal carbohydrates are dynamic. In other work, two different sialylated mucins were shown to have extended maturation times. An ascites tumor sialomucin, ASPG-1. was demonstrated to undergo sialylation after delivery to the plasma membrane, suggesting internalization and modification in the Golgi apparatus (14) . Likewise, the MUCl gene product episialin was demonstrated to be delivered in an immature form to the plasma membrane, followed by a slower maturation involving sialic acid addition (20) .
These data suggest that gp300 stored in zymogen granules may have more sialic acid and may be desialylated after delivery to the plasma membrane by exocytosis. The cellular half-life of gp300 is greater than 24 hr, as determined by pulse-chase immunoprecipitation analysis (not shown), suggesting that gp300 is likely to be reinternalized and transported back to the Golgi apparatus, where it would be packaged in new zymogen granules. We are now assessing whether the carbohydrate composition of gp300 in granules differs from that on the plasma membrane, and whether the relative MAA and PNA binding to gp300 is affected by secretory activity of the cell.
The function of oligosaccharides on gp300 is not yet clear. We have proposed that the sulfate on gp300 is involved in association of digestive enzymes of the granule content with the granule membrane. We have demonstrated that the sulfate on gp300 is on 0-linked oligosaccharides (8), which would therefore make these 0-linked sugars important to the function of gp300. During development, gp300 was shown to be sulfated by metabolic incorporation of [3?+sulfate. However, it was not possible to quantify the relative sulfate levels because of inability to label to isotopic equilibrium. In addition, the limited tissue available made it impossible to measure total sulfate levels on gp300. Sulfate has been found both in zymogen granule content and in zymogen granule membranes from various animal species (1, 22, 24) . In acinar cells of the mouse pancreas, as in other cells, sulfation of proteins occurs in the Golgi complex and the majority of the sulfate is routed to zymogen granules (1) . Some of the sulfate is secreted, but some remains cell-associated for prolonged periods of time. We have now identified the major sulfated protein of the mouse acinar cell, gp300, which is tightly adherent to the granule membrane (8). Sulfation is a widespread modification of secretory granule components in secretory cells throughout the body (2.17). There is not yet any direct evidence for the role these sulfated granule components play, but their widespread occurrence suggests that sulfation is functionally significant.
